COST-BENEFIT ANALYSIS OF A PRESCRIPTION DRUG MONITORING PROGRAM IN WISCONSIN

First Page		Document Content
Date: 2012-07-20 17:18:29 Pharmacology Pharmaceuticals policy Drugs Clinical pharmacology Medical prescription Patient safety Substance abuse Prescription medication Medicare Health Medicine Pharmaceutical sciences		COST-BENEFIT ANALYSIS OF A PRESCRIPTION DRUG MONITORING PROGRAM IN WISCONSIN Add to Reading List Source URL: cbkb.org Download Document from Source Website File Size: 1,12 MB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document